Paper190002
2'-Deoxy-2'-azidocytidine, a new inhibitor of DNA replication in mammalian cells.
Skoog L and 5 others. Eur J Biochem, 1977. Cited by 23 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. 2'-Deoxy-2'-azidocytidine, a new inhibitor of DNA replication in mammalian cells. Papers, record 190002. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/190002
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| DNA Replication | Major topic |
| Deoxycytidine | Major topic |
| Cell Line | |
| Cytidine | |
| DNA Polymerase I | |
| DNA Polymerase II | |
| DNA, Viral | |
| Depression, Chemical | |
| Kinetics | |
| Molecular Weight | |
| Polyomavirus |
Source PubMed
Cited by9
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 23 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 32,786,764 | Cell- and Polymerase-Selective Metabolic Labeling of Cellular RNA with 2'-Azidocytidine. | J Am Chem Soc | 2020 | https://conductscience.org/library/papers/32786764 | PubMed |
| 30,224,458 | Metal-free class Ie ribonucleotide reductase from pathogens initiates catalysis with a tyrosine-derived dihydroxyphenylalanine radical. | Proc Natl Acad Sci U S A | 2018 | https://conductscience.org/library/papers/30224458 | PubMed |
| 29,609,464 | Structural Basis for Superoxide Activation of Flavobacterium johnsoniae Class I Ribonucleotide Reductase and for Radical Initiation by Its Dimanganese Cofactor. | Biochemistry | 2018 | https://conductscience.org/library/papers/29609464 | PubMed |
| 21,925,541 | In vitro and in vivo efficacy of fluorodeoxycytidine analogs against highly pathogenic avian influenza H5N1, seasonal, and pandemic H1N1 virus infections. | Antiviral Res | 2011 | https://conductscience.org/library/papers/21925541 | PubMed |
| 2,991,751 | Linear simian virus 40 DNA fragments exhibit a propensity for rolling-circle replication. | Mol Cell Biol | 1985 | https://conductscience.org/library/papers/2991751 | PubMed |
| 225,549 | Polyoma DNA synthesis in isolated nuclei: evidence for defective replication forks. | J Virol | 1979 | https://conductscience.org/library/papers/225549 | PubMed |
| 206,720 | Effects of 2'-deoxy-2'-azidocytidine on polyoma virus DNA replication: evidence for rolling circle-type mechanism. | J Virol | 1978 | https://conductscience.org/library/papers/206720 | PubMed |
| 202,949 | 2'-Deoxy-2'-azidocytidine inhibits the initiation of polyoma DNA synthesis. | Proc Natl Acad Sci U S A | 1977 | https://conductscience.org/library/papers/202949 | PubMed |
| 198,575 | Characterization of the autoregulation of simian virus 40 gene A. | J Virol | 1977 | https://conductscience.org/library/papers/198575 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/190002
GET https://conductscience.org/api/papers/v1/190002/authors